Vertex Pharmaceuticals Inc at UBS BioPharma Conference Transcript
Good afternoon, and welcome to the UBS Biopharma Conference. I'm Colin Bristow, one of the biotech analyst here. It's my pleasure to have Vertex Pharmaceuticals with us here today.
On behalf of the company, we have Charlie Wagner, CFO; and David Altshuler, the Chief Scientific Officer. So thank you both for your time today.
Questions & Answers
Maybe we can just kick off with cystic fibrosis, obviously, a sort of major franchise for you guys, continue to show impressive quarter-on-quarter growth. But from an investor perspective, it feels that this is well understood. It's pretty well modeled. As you look at consensus estimates and you speak to investors, what do you think is underappreciated about this opportunity, if anything.
Yes, Colin, thanks for the question. Maybe I'll start
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
